m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma

Bibliographic Details
Title: m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma
Authors: Li Liu, Jing Wang, Guifeng Sun, Qiong Wu, Ji Ma, Xin Zhang, Nan Huang, Zhixuan Bian, Song Gu, Min Xu, Minzhi Yin, Fenyong Sun, Qiuhui Pan
Source: Molecular Cancer, Vol 18, Iss 1, Pp 1-13 (2019)
Publisher Information: BMC, 2019.
Publication Year: 2019
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: RNA m6A methylation, Wnt/β-catenin pathway, CTNNB1, Hepatoblastoma, METTL3, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Background N6-Methyladenosine (m6A) modification has been implicated in many biological processes. It is important for the regulation of messenger RNA (mRNA) stability, splicing, and translation. However, its role in cancer has not been studied in detail. Here we investigated the biological role and underlying mechanism of m6A modification in hepatoblastoma (HB). Methods We used Reverse transcription quantitative real-time PCR (RT-qPCR) and Western blotting to determine the expression of m6A related factors. And we clarified the effects of these factors on HB cells using cell proliferation assay, colony formation, apoptotic assay. Then we investigated of methyltransferase-like 13 (METTL3) and its correlation with clinicopathological features and used xenograft experiment to check METTL3 effect in vivo. m6A-Seq was used to profiled m6A transcriptome-wide in hepatoblastoma tumor tissue and normal tissue. Finally, methylated RNA immunoprecipitation (MeRIP) assay, RNA remaining assay to perform the regulator mechanism of MEETL3 on the target CTNNB1 in HB. Results In this research, we discovered that m6A modifications are increased in hepatoblastoma, and METTL3 is the main factor involved with aberrant m6A modification. We also profiled m6A across the whole transcriptome in hepatoblastoma tumor tissues and normal tissues. Our findings suggest that m6A is highly expressed in hepatoblastoma tumors. Also, m6A is enriched not only around the stop codon, but also around the coding sequence (CDS) region. Gene ontology analysis indicates that m6A mRNA methylation contributes significantly to regulate the Wnt/β-catenin pathway. Reduced m6A methylation can lead to a decrease in expression and stability of the CTNNB1. Conclusion Overall our findings suggest enhanced m6A mRNA methylation as an oncogenic mechanism in hepatoblastoma, METTL3 is significantly up-regulated in HB and promotes HB development. And identify CTNNB1 as a regulator of METTL3 guided m6A modification in HB.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1476-4598
Relation: https://doaj.org/toc/1476-4598
DOI: 10.1186/s12943-019-1119-7
Access URL: https://doaj.org/article/56bc649ea58440eba44ac8ef4d6af0ab
Accession Number: edsdoj.56bc649ea58440eba44ac8ef4d6af0ab
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:14764598
DOI:10.1186/s12943-019-1119-7
Published in:Molecular Cancer
Language:English